The dual discoveries of the TSH radioimmunoassay (10) and peripheral conversion of oral T4 to T3 in humans (11) provided clinicians with a quantifiable biomarker and more consistent thyroid hormone preparations with which to treat hypothyroidism. This evidence concerns the gene TG and hypothyroidism.